Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Novavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as quickly as planned. Novavax's product launched more than a year after those of rivals. This meant…
#nvax #gavi #novavax #adriacimino #motleyfool #novavaxstock